Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...
HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...
HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHTtm ? now ...
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...
EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...
A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...
Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
Researchers at Germans Trias i Pujol Research Institute (IGTP) have led a study that evaluates, for the first time, the ...
HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback